EUVIMEDEUVIMED entdecken
Crossref

L26/P-616 Clinical Application of Cost-Effective Nanopore Adaptive Sampling for Preimplantation Genetic Testing

Z. Zhang, S. He, X. Liang, C. Fang, T. Ding, X. Wang, J. Yang, Y. Zou, S. Lu, H. Zeng

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Z. Zhang und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can nanopore adaptive sampling provide a cost-effective and accurate approach for combined preimplantation genetic testing for monogenic disorders (PGT-M) and chromosomal structural rearrangements (PGT-SR)? Summary answer Nanopore adaptive sampling enables simultaneous detection of pathogenic mutations and translocations, supports haplotype linkage analysis, and significantly reduces sequencing costs, demonstrating its feasibility for PGT. What is known already Traditional PGT relies on next-generation sequencing (NGS) and requires complete pedigree genetic information for haplotype analysis, limiting its use in cases of incomplete pedigrees or de novo mutations. While third generation sequencing (TGS) offers long reads that can encompass pathogenic variants and linked SNPs in a single read, facilitating direct haplotype construction, its high cost hinders widespread clinical adoption. Targeted sequencing methods have been proposed to reduce costs, but often involve complex primer/probe design and wet-lab steps. Study design, size, duration This prospective study included eight couples undergoing PGT between February 2021 and October 2024. Five couples carried both balanced chromosomal translocations and HBB gene mutations, and three couples carried monogenic disease mutations (in PKD1, ASNS, or ALPL). A total of 51 embryos were analyzed. Participants/materials, setting, methods Parental peripheral blood DNA was sequenced using nanopore adaptive sampling to enrich for regions containing translocation breakpoints and disease-associated mutations. Embryonic trophectoderm biopsies underwent whole-genome amplification (WGA), followed by low-coverage NGS for copy number variant detection and microarray-based SNP genotyping. Haplotype linkage analysis was performed using both adaptive sampling data and microarray results. Embryo genotypes were validated by Sanger sequencing, and prenatal diagnosis confirmed PGT outcomes. Main results and the role of chance Nanopore adaptive sampling achieved a mean target region depth of 26× and an average enrichment factor of 10.28 compared to whole-genome sequencing. It successfully identified all pathogenic mutations and translocation breakpoints at single-base resolution. Haplotype linkage analysis results from adaptive sampling were fully concordant with microarray-based data. Six families achieved clinical pregnancy after transfer of embryos selected using this method, and prenatal diagnosis in five families confirmed PGT predictions. Limitations, reasons for caution Enrichment efficiency of adaptive sampling was modest (∼7%), resulting in significant off-target sequencing. Additionally, embryo genotyping relied on WGA, which may introduce allele dropout (ADO) and amplification bias. The method was not applied directly to amplified embryonic DNA due to its reliance on long, native DNA fragments. Wider implications of the findings Nanopore adaptive sampling provides a flexible, cost-effective targeted sequencing strategy that maintains the long-read advantages of TGS while reducing costs by approximately 50–60%. It is particularly suitable for cases with incomplete pedigrees and de novo mutations, and may pave the way for more integrated PGT approaches in the future. Trial registration number Yes

Zitieren

APA

Zhang, Z., He, S., Liang, X., Fang, C., Ding, T., Wang, X., Yang, J., Zou, Y., Lu, S., & Zeng, H. (2026). L26/P-616 Clinical Application of Cost-Effective Nanopore Adaptive Sampling for Preimplantation Genetic Testing. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.946

Vancouver

Zhang Z, He S, Liang X, Fang C, Ding T, Wang X, et al. L26/P-616 Clinical Application of Cost-Effective Nanopore Adaptive Sampling for Preimplantation Genetic Testing. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.946

BibTeX
@article{Zhang2026,
  author = {Zhang, Z. and He, S. and Liang, X. and Fang, C. and Ding, T. and Wang, X. and Yang, J. and Zou, Y. and Lu, S. and Zeng, H.},
  title = {L26/P-616 Clinical Application of Cost-Effective Nanopore Adaptive Sampling for Preimplantation Genetic Testing},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.946}
}
Kostenlos starten →